ENDOBIOLOGICS INTERNATIONAL
EndoBiologics International Corporation develops technology for manufacturing subunit and conjugate vaccines that contain detoxified polysaccharides from bacterial lipopolysaccharide (LPS). The company was formerly known as Montana Headwaters. It was founded in 1997 and is based in Missoula, Montana.
ENDOBIOLOGICS INTERNATIONAL
Social Links:
Industry:
Biotechnology Health Care Manufacturing Medical
Founded:
1997-01-01
Address:
Missoula, Montana, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
1.35 M USD
Similar Organizations
Innovasis
Innovasis focuses on research, development, manufacturing, and marketing of spinal implant devices and related products.
MarDx Diagnostics
MarDx Diagnostics is engages in developing, manufacturing, and marketing diagnostic products.
PlasmaSol
PlasmaSol is developing sterilization technology for medical instruments and for protecting indoor air quality.
Current Employees Featured
More informations about "EndoBiologics International"
EndoBiologics International - Contacts, Employees, Board โฆ
EndoBiologics International develops technology for manufacturing subunit and conjugate vaccines with detoxified polysaccharides.See details»
EndoBiologics International - Funding, Financials, Valuation
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Aug 13, 2010: ... Apr 26, 2010: โฆSee details»
Endobiologics International Corp in Missoula, Montana - EIN TaxId
Endobiologics International Corp is a corporation in Missoula, Montana. The employer identification number (EIN) for Endobiologics International Corp is 911995377. EIN for โฆSee details»
EndoBiologics International Corporation Company Profile, โฆ
EndoBiologics International Corporation develops technology for manufacturing subunit and conjugate vaccines that contain detoxified polysaccharides from bacterial lipopolysaccharide โฆSee details»
ENDOBIOLOGICS INTERNATIONAL CORP. | SBIR.gov
This project develops a conjugate vaccine against Shigella flexneri 2a utilizing cGMP-compatible manufacturing processes. The antigenic component of the vaccine is deacylated โฆSee details»
Endobiologics International Corporation · 711 Capitol Way S Ste โฆ
ENDOBIOLOGICS INTERNATIONAL CORPORATION is a business entity in , registered with the Secretary of State of Washington State. The Unified Business Identifier (UBI) of the entity is โฆSee details»
EndoBiologics International Corp Company Profile, Financial and ...
DigitGaps report on EndoBiologics International Corp delivers a detailed in-depth and comprehensive insights of the company, its history, corporate strategy, its businesses and โฆSee details»
ENDOBIOLOGICS INTERNATIONAL CORP (Form Type: D, Filing โฆ
Over Five Years Ago โ Within Last Five Years (Specify Year) โSee details»
Annual Report on Endobiologics International's Revenue, Growth, โฆ
Determine whether Endobiologics International grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how โฆSee details»
VaxGen signs research deal with EndoBiologics International Corp โฆ
Missoula, Mont.-based EndoBiologics is a privately held company which does research for the government on a vaccine against bacterial dysentery. Skip to content. Menu. Home; ...See details»
EndoBiologics, VaxGen target meningitis B | Drug Discovery News
Vaccine specialist VaxGen recently announced a collaborative effort with privately held biotechnology company EndoBiologics International to pursue research into a vaccine that โฆSee details»
ENDOBIOLOGICS INTERNATIONAL CORP - HIPAASpace
ENDOBIOLOGICS INTERNATIONAL CORP. Conformed submission company name, business name, organization name, etc. 1105098. Company's CIK. Company's Central Index Key (CIK). โฆSee details»
VaxGen and EndoBiologics form collaboration t | EurekAlert!
May 4, 2005 VaxGen, Inc. (Pink Sheets: VXGN.PK) and EndoBiologics International Corp. announced today that they have formed a collaboration to pursue research of a vaccine โฆSee details»
EndoBiologics International - Crunchbase
EndoBiologics International develops technology for manufacturing subunit and conjugate vaccines with detoxified polysaccharides.See details»
EndoBiologics International-ๅจ่็ฝ - vbdata.cn
EndoBiologics International Corporationๅผๅ็จไบ็ไบงไบๅไฝๅ็ปๅ็ซ่็ๆๆฏ๏ผๅ ถๅซๆๆฅ่ช็ป่่ๅค็ณ๏ผLPS๏ผ็่ฑๆฏๅค็ณใ่ฏฅๅ ฌๅธไปฅๅ็งฐไธบ่ๅคงๆฟๅทไธๆธธใๅฎๆ็ซไบ1997ๅนด๏ผๆป้จ่ฎพๅจ่ๅคง โฆSee details»
Venture Round - EndoBiologics International - 2010-04-26
EndoBiologics International raised $1100000 on 2010-04-26 in Venture Round. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... Venture Round - โฆSee details»
Global, regional, and national burden of infective endocarditis โฆ
Mar 24, 2025 To comprehensively evaluate the global, regional, and national burden of infective endocarditis (IE) from 2010 to 2021, and to project future trends. This study utilized data from โฆSee details»
Secure cloud exposure with Tenable Cloud Security | Tenable®
Cloud security at Tenable starts with a unified CNAPP powerful enough to manage posture, secure workloads, govern identity & access management, and much more.See details»
Endoscopy International Open - Journals - Thieme Group
Endoscopy International Open (EIO) is an open access journal in the field of gastrointestinal endoscopy. It covers all aspects of endoscopic diagnosis, therapeutic procedures and โฆSee details»
Venture Round - EndoBiologics International - 2010-08-13
EndoBiologics International raised $250000 on 2010-08-13 in Venture Round. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... Venture Round - โฆSee details»